{
  "source_file": "wst-20250930.htm",
  "form_type": "10-Q",
  "item1_clean": null,
  "item7_clean": null,
  "item2_clean": ", as compared to the same period in\n, due primarily to the Company recording expense of $0.9 million to related to restructuring and other charges during the three months ended September 30, 2025, as compared to a net benefit of $2.5 million during the same period in 2024.\nCorporate and unallocated items changed by $15.1 million for the nine months ended September 30, 2025, as compared to the same period in 2024, due primarily to the Company recording expense of $17.5 million related to restructuring and other charges in the nine months ended September 30, 2025, as compared to a net benefit of $2.5 million during the same period in 2024.\nThe following table presents adjusted operating profit, consolidated and by reportable segment, corporate and unallocated items:\nProprietary Products\nContract-Manufactured Products\nCorporate and unallocated items\nConsolidated operating profit\nConsolidated operating profit margin\nAdjusted consolidated operating profit\nAdjusted consolidated operating profit margin\nConsolidated operating profit increased by $6.3 million, or 3.9%, for the three months ended September 30, 2025, as compared to the same period in 2024, including a favorable foreign currency translation impact of $7.3 million for the three months ended September 30, 2025, as compared to the same period in 2024.\nConsolidated operating profit increased by $18.0 million, or 4.4%, for the nine months ended September 30, 2025, as compared to the same period in 2024, including a favorable foreign currency translation impact of $10.5 million for the nine months ended September 30, 2025, as compared to the same period in 2024.\nProprietary Products -\nProprietary Products operating profit increased by $17.0 million, or 10.7%, for the three months ended September 30, 2025, as compared to the same period in 2024, including a favorable foreign currency translation impa\n, due to the factors described above, most no\ntably higher plant absorption from increased customer demand and sales price increases.\nProprietary Products operating profit increased by $52.0 million, or 12.5%, for the nine months ended September 30, 2025, as compared to the same period in 2024, including a favorable foreign currency translation impact of $9.6 million, due to the factors described above, most notably higher plant absorption from increased customer demand and sales price increases.\nContract-Manufactured Produ\nContract-Manufactured Products operating profit increased by\n, or 2.3%, for the three months ended September 30, 2025, as compared to the same period in 2024, including a favorable foreign currency translation impact of\n, due to the factors described abov\nContract-Manufactured Products operating profit\nSeptember 30, 2025, as compared to the same period in 2024, including a favorable foreign currency translation impact of\n, due to the factors described above,\nmost notably increased salary and wages.\nCorporate and unallocated -\nExcluding the unallocated items, Corporate costs increased by $8.0 million, or 41.2%, for the three months ended September 30, 2025, as compared\nto the same period in 2024, due to the factors described above, most not\nably the increase in expense related to stock-based compensation.\nExcluding the unallocated items, Corporate costs increased by $9.1 million, or 14.8%, for the nine months ended September 30, 2025, as compared\nto the same period in 2024, due to the factors described above, most notably\nthe higher annual incentive compensation.\nFor unallocated items, please refer to the Financial Performance Summary section above for details.\nInterest Expense, Net and Interest Income\nThe following table presents interest expense, net, by significant component:\nCapitalized interest\nInterest expense, net\nInterest expense, net, decreased by $0.5 million, for the three months ended September 30, 2025, as compared to the same period in 2024, due primarily to a decline in interest rates in 2025, as compared to the same periods in 2024. Interest expense, net, decreased by $3.1 million, for the nine months ended September 30, 2025, as compared to the same period in 2024, due primarily to an increase in capitalized interest.\nInterest income increased by $0.1 million for the three months ended September 30, 2025, as compared to the same period in 2024. Interest income decreased by $2.4 million for the nine months ended September 30, 2025, as compared to the same period in 2024, due primarily to a decline in interest rates in 2025, as compared to the same periods in 2024.\nOther Nonoperating Expense (Income)\nOther nonoperating expense (income) was $0.2 million and $0.7 million for the three months ended September 30, 2025 and 2024, respectively, and $0.6 million and $0.7 million for the nine months ended September 30, 2025 and 2024, respectively.\nThe provision for income taxes was $34.0 million and $32.4 million for the three months ended September 30, 2025 and 2024, respectively, and the effective tax rate was 19.8% and 19.7%, respectively.\nThe provision for income taxes was $88.3 million and $70.7 million for the nine months ended September 30, 2025 and 2024, respectively, and the effective tax rate was 20.1% and 16.8%, respectively. The increase in the effective tax rate is due primarily to a decrease in the tax benefit related to stock-based compensation in the nine months ended September 30, 2025 as compared to the same period in 2024.\nEquity in Net Income of Affiliated Companies\nEquity in net income of affiliated companies was $2.1 million and $3.9 million for the three months ended September 30, 2025 and 2024, respectively. Equity in net income of affiliated companies decreased by $1.8 million for the three months ended September 30, 2025, as compared to the same period in 2024, due primarily to less favorable operating results at Daikyo and the Mexico affiliates.\nEquity in net income of affiliated companies was $10.5 million and $12.7 million for the nine months ended September 30, 2025 and 2024, respectively. Equity in net income of affiliated companies decreased by $2.2 million for the nine months ended September 30, 2025, as compared to the same period in 2024, due primarily to less favorable operating results at Daikyo, partially offset by more favorable operating results at the Mexico affiliates.\nFINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES\nThe following table presents cash flow data for the nine months ended September 30:\nNet cash provided by operating activities\nNet cash used in investing activities\nNet cash used in financing activities\nNet Cash Provided by Operating Activities –\nNet cash provided by operating activities increased by $40.4 million for the nine months ended September 30, 2025, as compared to the same period in 2024, due primarily to favorable working capital management.\nNet Cash Used in Investing Activities –\nNet cash used in investing activities decreased by $64.1 million for the nine months ended September 30, 2025, as compared to the same period in 2024, due primarily to a decrease in capital expenditures.\nNet Cash Used in Financing Activities –\nNet cash used in financing activities decreased by $380.3 million for the nine months ended September 30, 2025, as compared to the same period in 2024, due primarily to a decrease in purchases under our share repurchase programs.\nLiquidity and Capital Resources\nThe table below presents selected liquidity and capital measures:\nCash and cash equivalents\nAccounts receivable, net\nCash and cash equivalents include all instruments that have maturities of ninety days or less when purchased. Working capital is defined as current assets less current liabilities.\nCash and cash equivalents –\nOur cash and cash equivalents balance at September 30, 2025 consisted of cash held in depository accounts with banks around the world and cash invested in high-quality, short-term investments. The cash and cash equivalents balance at September 30, 2025 included $96.6 million of cash held by subsidiaries within the U.S., and $531.9 million of cash held by subsidiaries outside of the U.S. During the nine months ended September 30, 2025, we purchased 552,593 shares of our common stock under the share repurchase program at a cost of $134.0 million, or an average price of $242.55 per share.\nWorking capital at September 30, 2025 increased by $200.2 million, or 20.3%, as compared to December 31, 2024, which includes a favorable foreign currency translation impact of\n. Excluding the impact of currency exchange rates, cash and cash equivalents, total current liabilities, accounts receivable and inventories\n$118.8 million, $53.9 million, $43.4 million and $36.4 million\nin cash and cash equivalents was\ndue to cash from operations, partially offset by share repurchases and capital expenditures during the nine months ended September 30, 2025.\nin total current liabilities was\ndriven by increases in our annual incentives and short-term hedge liabilities. The increase in accounts receivable was due to increased net sales leading up to the\nbalance sheet date as compared to the\nin inventories was to ensure we have sufficient inventory on hand to support the needs of our customers\nDebt and credit facilities –\nThe total debt balance of $202.7 million at September 30, 2025 increased $0.1 million from the total debt balance at December 31, 2024.\nOur sources of liquidity include our multi-currency revolving credit facility. At September 30, 2025, we had no outstanding borrowings under the multi-currency revolving credit facility. At September 30, 2025, the borrowing capacity available under the multi-currency revolving credit facility, including outstanding letters of credit of $2.3 million, was $497.7 million. We do not expect any significant limitations on our ability to access this source of funds.\nPursuant to the financial covenants in our debt agreements, we are required to maintain established interest coverage ratios and not to exceed established leverage ratios. In addition, the agreements conta"
}